Alluvi tirzepatide has been emerged as a promising therapeutic option for the treatment of metabolic diseases. This preclinical evaluation explored the efficacy and safety of tirzepatide 40mg in experimental models of insulin resistance. The experiments demonstrated that tirzepatide 40mg markedly enhanced glycemic control and reduced insulin sensit